Cancer

New Multi-Cancer Early Detection Data Presented at ASCO 2023

The study's multi-cancer early detection data show Exai's RNA- and AI-based platform can detect multiple cancer types at the earliest stages using a single, standard blood sample.

Cancer

PROphet Biomarker Model Results to be Presented

OncoHost will give a poster presentation demonstrating the accuracy of its PROphet biomarker model at the upcoming 2023 ASCO Annual Meeting.

Cancer

FDA Approves xT Cdx NGS-Based In Vitro Diagnostic Device

xT CDx is a 648-gene next-generation sequencing test for solid tumor profiling, which includes microsatellite instability status and companion diagnostic claims for colorectal cancer patients.

Early Detection of Prostate Cancer Guideline Released

Apr 25, 2023 | Prostate

The American Urological Association and Society of Urologic Oncology have released the 2023 clinical practice guideline on the early detection of prostate cancer.

Blood-Based Colorectal Cancer Test Is Now Available

Apr 21, 2023 | Colorectal

Beacon Biomedical announced the availability of its BeScreened Colorectal Cancer (CRC) test at Any Lab Test Now locations across the nation.

Adela Diagnostic Platform Detects 12 Cancer Types

Apr 19, 2023 | Cancer

Adela demonstrated the ability of its genome-wide methylome enrichment platform to detect a broad set of diverse cancers in early stages.

Exai Bio Presents New Non-Small Cell Lung Cancer Early Detection Data

Apr 18, 2023 | Lung Cancer

New data demonstrates Exai Bio’s novel RNA- and AI-based platform detected non-small cell lung cancer with high accuracy.

New Test for Detecting Cancer Biomarkers

Apr 18, 2023 | Cancer

A team led by Florida State University chemists developed a new test for detecting biomarkers related to several types of cancer.

CGP Assay for Solid Tumor Types Introduced

Apr 14, 2023 | Cancer

Agilent Technologies Inc. has launched the Agilent SureSelect Cancer CGP Assay for somatic variant profiling for a range of solid tumors.

Is an Artificial Pathologist Possible?

Apr 14, 2023 | Cancer, Microscopy, Specimen Collection & Handling

A team from the Max Planck Institute use artificial intelligence to evaluate surgical biopsy data, creating a kind of artificial pathologist.

Cancer Database’s Cases Dropped 14% in Pandemic’s First Year

Apr 13, 2023 | Cancer

Researchers say newly reported cases of cancer diagnoses declined 14.4% in 2020 compared with prior years.

Adaptive Biotechnologies Assay Measure’s MRD for Takeda Cancer Treatments

Apr 12, 2023 | Cancer

The collaboration will cover programs to aid the development and commercialization of investigational medicines for hematologic malignancies.

Foundation Medicine and Bristol Myers Squibb Expand Collab on CDx Development

Apr 11, 2023 | Cancer

Foundation Medicine and Bristol Myers Squibb are developing the FoundationOne CDx as a companion diagnostic for repotrectinib.

A Majority of Saudi Arabians Skip Colon Cancer Testing

Apr 11, 2023 | Colorectal

A new report shows Saudi Arabia has a high percentage of respondents who never took colon cancer tests, far higher than the global average.

Blood-Based Colon Cancer Test Provides Early Detection

Apr 10, 2023 | Colorectal

Beacon Biomedical released a colon cancer screening test designed to improve access and affordability to CRC screening as a blood draw.

Transfer RNA Biomarkers for Cancer Diagnosis Enabled by New Method

Apr 7, 2023 | Cancer, Molecular Diagnostics

A new method of measuring tRNA in blood samples offers a simple and highly-precise alternative to invasive diagnostic and prognostic methods.

Blood Biomarkers Predict Neuroendocrine Tumor Response to Radiopharmaceutical Therapy

Apr 7, 2023 | Unknown Origin & Other Cancer Types

A simple blood draw can help determine if peptide receptor radionuclide therapy is effective in a patient with neuroendocrine cancer.

Guardant Health and Ohio State University to Study Colon Cancer Screening Adherence

Apr 6, 2023 | Colorectal

Guardant Health and Ohio State University will evaluate patient compliance with a blood-based test for colorectal cancer (CRC) screening.

Category: Cancer

Cancer

Cancer

Cancer